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Abstract  
One of the most prominent addictions of the modern age is to opioids. While opioids               
originated as a pain relief treatment, their use has increased in the United States steadily since                
1990. To study the impact of opioids on a compact neurological system, the model roundworm               
Caenorhabditis elegans was used. β-Endorphin, an endogenous human opioid, was administered           
to ​C. elegans and observed for changes in locomotive behavior. Our results revealed a reduction               
of speed of the worms treated with β-Endorphin versus a water control. These findings suggest               
that β-Endorphin has an effect on ​C. elegans and can be useful model in studying addiction in                 
these systems 
Introduction 
Addiction is defined as using a substance or acting in a behavior that results in a 
rewarding effect (Addiction, n.d.). Addiction substances can include, alcohol, opioids, nicotine 
and behaviors like gambling. These substances and behaviors activate the reward pathway due to 
the neurological release of dopamine. This pathway reinforces behaviors that become difficult to 
control. Addiction can disrupt relationships and other obligations, as well as degrade the body. 
One of the most destructive addictions of the modern era is to opioids.  
Opioids are a class of medication used for pain relief treatment. Commonly, they are used 
for short term treatment, like after surgery. Their main purpose is to attach to receptors in the 
brain to block pain signaling. Opioids include prescription medications like Morphine, Codeine, 
Percocet, Oxycodone, and illicit drugs like Heroin (The National, 2014). Medical use of opioids 
has increased their use within the United States. The peak of opioid prescriptions occurred in 
2012, to a total of 81.3 prescriptions per 100 patients in the United States. This number has 
declined to 58.5 in 2017 (Opioid, 2018). However, even though a decline in prescriptions has 
occurred, overdose deaths have continued to increase. Both prescription and illicit opioids 
contribute to overdose deaths.  
Opioid addiction in Massachusetts has shown a similar trend. In 2015, Massachusetts 
prescribed 59.9 opiates per 100 patients (National, 2018). Figure 1 shows the opioid related 
overdose deaths of Massachusetts residents from 2000 through 2017. The number of opioid 
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related overdose deaths peaked in 2016, where it was estimated that 2,154 people died due to 
opioid overdose. In 2000, the number of overdose deaths was 379, less than 5 times as many 
deaths than when compared to 2016. There is a correlation between the increase of prescriptions 
and the increase of opioid related overdose deaths.  
 
 
Figure 1: ​Opioid Overdose Deaths in Massachusetts (Data, 2018).  
 
Addiction to opioids in humans is a common side effect due to prescriptions 
post-hospitalization. Between 21 and 29 percent of patients with prescriptions for opioids misuse 
them. Opioids are common pain medications due to their ability to relax the body and ease pain. 
Common prescription opioids include Vicodin, Oxycontin, Percocets, Morphine, and Codeine 
(NIDI, 2018).  Physical side effects from opioids include drowsiness, confusion, nausea, 
constipation, euphoria, and slowed breathing. Slowed breathing can result in a  more intense 
condition called hypoxia, where the brain does not receive enough oxygen. Hypoxia can cause 
coma, brain damage, and even death. Opioid addiction has become such a prevalent issue across 
the United States, that it has been deemed an epidemic. This is supported by the fact that about 
80%, of heroin users began with misuse of prescription opioids (National, 2018). 
Addiction to opioids is challenging to overcome. Physical dependence is the main reason 
why it is difficult for patients to overcome addiction. Opioids are best prescribed for short term 
pain regulation, due to tolerance development. When patients become tolerant to opioids, they 
can experience withdrawal when their prescription is complete. Symptoms of withdrawal include 
runny nose and eyes, muscle aches, anxiety, agitation, nausea, and more. Dependence on opioids 
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can occur even when taking the medication as prescribed by a licensed physician.Opioid abuse 
is characterized by “misusing opioids with the intention to get high or avoid withdrawal 
symptoms” (Merchant, 2017 ) . 
Studies about opioid addiction can not be studied in human subjects due to ethical 
concerns. Therefore, the purpose of this study is to observe the effect that exposure to opioid-like 
analogs have on normal  ​C. elegans ​behaviors. he analog being tested is β-Endorphin. This is an 
endogenous opioid produced in humans. Since β-Endorphin is not produced in ​C. elegans​, it 
could be considered to be a synthetic treatment. This is a parallel to how prescription opiates are 
synthetic to humans.  
Background 
Opioids 
The first discovery of opioids occurred in 1804, when morphine was first extracted from 
opium poppy (Mitchell, 2017). It was used for medicinal pain relief, but side effects made 
scientists hope to find an opiate alternative that did not cause tolerance to the drug. In 1896, 
heroin was developed and claimed to be less addictive than previous medicinal opioids. 
Oxycodone was developed in 1916, which was beneficial for patients with short term injuries. 
Experimental trials on the effects of these opiates did not begin until the 1930’s.  
However, Purdue Pharma is currently being sued by the state of Colorado, and 5 other 
states due to wrongful marketing and misrepresentation of the side effects of OxyContin and 
other opioid pain relievers  (Moritz, 2018). Some of the claims include; failing to disclose 
addiction risk of opiates, not claiming a maximum dosage that was dangerous to patients, 
claiming that  addiction symptoms mean that patients need to increase their dosage, and claiming 
that their formula reduces risk of addiction in general.  
Mechanism of Action of Opioids 
Opioids bind to opioid receptors within the body. While there are a multitude of 
receptors, all have similar activation responses. When an opioid binds, the bound guanosine 
diphosphate (GDP)  is replaced by a guanosine triphosphate (GTP) on the ​α subunit (Pathan, 
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2012)​. The new  ​α-GTP is removed from the structure. Adenylyl cyclase is inhibited and cyclic 
adenosine monophosphate is reduced. For neuronal cells, this reduction caused a reduction in 
released neurotransmitters. This pathway is shown in Figure 2. 
 
Figure 2: ​Opioid binding activation pathway​ ​(Pathan, 2012). 
Opioid Receptors 
Opioid receptors belong to a class of 7 transmembrane spanning (7TM) G-protein 
coupled receptors (Feng, 2012). This class of receptors help to mediate both neurotransmitter and 
hormonal action within humans. These receptors can be activated by two types of opioids, 
exogenous and endogenous.  Exogenous opioids are administered outside of the body, while 
exogenous opioids originate naturally within the body.  
Opioids interact with opioid receptors found on neuronal cell membranes. This coupling 
action induces a signaling cascade via a G-coupled receptor that, in humans, induces a variety of 
effects. Opioids, such as morphine, can produce extreme mood changes, addictive symptoms, 
and general physical dependence as they induce a ‘reward’ sense. In humans these receptors 
come in three different types δ, μ, κ, and NOR receptor variants. These receptors can be found in 
both the peripheral and central nervous systems. In humans, opioids act in a twofold manner on 
the nervous system, at the presynaptic terminal as well as the postsynaptic neuron. In the 
postsynaptic case, opioids have inhibitory actions, hastening the release of neurotransmitters, but 
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in the presynaptic condition, opioids amplify their corresponding neuronal response, including 
that of the post neuronal case (Chahl, 1996). 
There are three types of opioid receptors that have been cloned; MOR, DOR, and KOR. 
These receptors are present in the body for many reasons. These include pain modulation, 
regulation of membrane ionic homeostasis, cell proliferation, emotional response, immune 
function, feeding, cardiovascular control and more (Feng). Not much is known about all types of 
opioid receptors, but DOR has been shown to mediate neuro and cardio protection. Upregulation 
of the DOR increases neural tolerance to hypoxic stress.  
 ​C. elegans​ lack particular opioid structures that are evident in vertebrates, with no 
comparable ortholog genes nor antagonists (Cheong, 2015). However, they have many  peptides 
and structures  similar to vertebrate opioid receptors. ​C. elegans​ have ​FMRFamide-related 
peptides (FaRPs) or Neuropeptide Receptor 17’s (NPR-17s), which are structurally and 
functionally similar to vertebrate opioid receptor (Cheong).​ Several studies have been conducted 
to illustrate the effects that opiates can have on worm behavior and physiological function. These 
studies pertain mostly to noireception (pain modulation) or feeding behavior, two common 
research areas of opioid addiction. In the case of feeding behavior opioids were shown to affect 
the pharyngeal pumping speed, illustrating that they have an effect on a worm physiologically 
and behavior, similar to vertebrate cases  (Chahl, 1996).  
 
 
Figure 3: ​Reward pathway in the human brain (pdb101.rcsb.org) 
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Opioid Use Within The WPI Community 
A study was conducted to gain insight about misconceptions of opioids at WPI. The goal 
of the study was to determine how comfortable WPI students are with opioids. Another goal was 
to determine how students may be able to access opioids while at college, whether it be 
medically or recreationally.  
The survey began with simple questions asking if students had received any substance 
abuse trainings during high school or while at college. Most of the respondents had participated 
in a training within the past 5 years. The topics covered by these trainings was varied, including 
drinking, recreational drug use, peer pressure, risk awareness, and more. The survey then 
transitioned into asking specifically about opioids. Opioids were first defined, and then 
respondents were asked how comfortable would they feel taking an opioid if prescribed by a 
medical provider. The spread of responses can be seen down below in Figure 4​. ​More than 60% 
of survey respondents would be uncomfortable to extremely uncomfortable with taking opiates, 
even when prescribed by a medical professional. About 32% of respondents would be 
comfortable to extremely comfortable when taking opiates prescribed by a medical professional. 
Overall, students at WPI are likely to be uncomfortable than comfortable when taking prescribed 
opioids.  
 
Figure 4: ​Comfort level of WPI students with medically prescribed opiates. 
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 The survey then asked if respondents had ever been prescribed an opiate by a medical 
professional. Responses can be seen below in Figure 5​. ​64% of survey respondents had not been 
prescribed an opiate. However, 35% of respondents had been prescribed an opiate. 22 of the 60 
survey respondents were able to have access to opiates through prescriptions. An interesting 
correlation between the comfort of WPI students with opiates and those who have been 
prescribed them. An assumption would be that most of the students that have had opiate 
prescriptions would be comfortable with them. However, of the 22 who have been prescribed 
opiates, 8 are somewhat comfortable. 7 of the students who have been prescribed opiates are 
extremely comfortable. The only other response that was extremely comfortable had not been 
prescribed an opiate. However, the 7 other students who have been prescribed opiates would be 
somewhat uncomfortable taking them. This was an unexpected result, but shows that even after 
having a legal experience with opiates, they can still cause some discomfort.  
 
Figure 5: ​Opioid prescriptions of WPI students.  
 
The survey then asked respondents if they knew of anybody taking opiates for both their 
prescribed use, as well as if they knew anybody who had abused them. At least 38% of 
respondents knew of somebody who has abused opiates as a way to get high or avoid withdrawal 
symptoms. However, 91% of respondents knew that using opiates outside of their prescribed 
purpose was very unsafe. While knowledge about the danger of opioids seems to be clear to WPI 
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students, there is still dangerous opioid abuse happening to acquaintances of WPI students. The 
survey then asked respondents how likely it was for college students to have access to opioids 
recreationally. Responses can be seen in Figure 6​. ​Almost 60% of respondents believe that it is 
somewhat or extremely likely for college students to be offered recreational opioids.  
 
Figure 6: ​Likelihood of college student to recreationally access opioids. 
 
​Overall, WPI students tend to be cautious about taking opioids, even when prescribed by 
a medical professional. However, WPI students are still able to access opioids. Students have 
access to opioids through prescriptions, as shown in Figure 5.​ ​However, based upon Figure 6​, ​it 
is possible that students also have illicit access to opiates through recreational use. This makes 
college students able to access opioids through two different routes. This makes college students 
twice as likely to be susceptible to opioid addiction.  
β-Endorphin 
β-Endorphins are a class of hormones secreted in human nervous systems that function as 
natural pain suppression. They are primarily synthesized and stored in the anterior pituitary 
gland. Some immune cells, lymphocytes and macrophages have been found to contain 
β-Endorphins (​Sprouse-Blum, 2010​). β-Endorphins act  post and pre synaptically to mediate pain 
responses on opioid receptors located in the peripheral nervous system (PNS).  
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β-Endorphins are secreted from the antuitary pituitary gland. Figure 7 illustrates the 
molecular structure of β-Endorphin. Similar to prescription opioids,they bind primarily to MOR 
receptors located in the olfactory bulb, spinal cord, and the cerebral cortex. It is anticipated since 
it binds to the same receptor that it will act similarly to other opioids, especially ones used for 
medical purposes. β-Endorphins are naturally occurring, and increase during traumatic 
experiences like surgery. Opioids are then prescribed to continue pain treatment, copying the 
action of natural β-Endorphins (​Sprouse-Blum​). 
 
 
Figure 7:​ Molecular Structure of β-Endorphin  (Sprouse-Blum) 
Caenorhabditis elegans 
Caenorhabditis elegans​ (​C. elegans​) are a model organism used to test neurological 
functions on a smaller, less complex scale than other model systems. ​C. elegans​ are a small, 
mostly hermaphroditic (with a small percentage of males), nematodes that are globally abundant 
in soils and are easily cultivable in a laboratory environment (Riddle, 1997). They have a 3 day 
life cycle, which involves four larval stages, a young adult stage, and a mature adult stage in 
which mature adults (who can self fertilize or be fertilized by males) can lay eggs that yield 
viable progeny.  The worms are small in size, measuring about 1.5 mm as an adult, and thus can 
be held on small petri dishes containing ​E. coli​ and nutrient growth media (Riddle). It is possible 
to maintain large population sizes in laboratory settings when using.​ E. coli ​(OP 50 strain) as a 
primary food source. The “worm” model can be used for various applications, from neuronal, 
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pathological, and genetic research. ​C. elegans​ have a small genome, which is only 20 times 
larger than its food source, ​E. coli ​(Riddle). ​C. elegans​ maintain a very small anatomical 
structure and a relatively small neurological layout, which in hermaphrodites is only 959 somatic 
cells and 302 neuronal cells (Hermaphrodite, n.d). This neuronal simplicity makes the ​C. elegans 
model ideal for neurological and behavioral testing. ​C. elegans​ complete simple functions with 
their nervous system, such as locomotion, foraging, feeding, and interacting in response to 
stimuli in their environment with pheranial cilia. This relatively simple neurological layout still 
can yield complex behavioral actions.  
Locomotion of ​C. elegans 
C. elegans​ have 75 innervated motoneurons that enable them to move forward and 
backward.In order to create thrust, ​C. elegans​ bend in the direction they wish to move. When 
swimming, the wavelength of undulation is greater than their body length, but on a surface such 
as agar the wavelength of undulation is much less than their body length (Gjorgjieva, 2014).  The 
type of motion of ​C. elegans​ can be defined into four categories: forward locomotion, backward 
locomotion, dwelling, and quiescence.  
Steering is controlled by muscle cells in the head and neck that can freely move 
compared to the rest of their muscular structure. ​C. elegans​ have both chemical neuromuscular 
junctions and gap junctions (Gjorgjieva). These muscles are all anchored throughout the body of 
C. elegans​. 
There are many different types of motoneurons within ​C. elegans​. Each have different 
functions and structure in order to cause movement within the muscles of ​C. elegans 
(Gjorgjieva). It is probable that all excitatory motor neurons show activity at the side they 
innervate, during dorsoventral bending.  
The exact nature of ​C. elegans​ locomotion pattern is still unknown. There are three main 
hypothesis about how locomotion patterns begin. One theory is that neck muscles create 
rhythmic bends and other mechanisms propagate this activity throughout the rest of the body. 
The second idea is that there are coupled oscillators throughout the body that relay the same 
pattern at the same time. The third hypothesis is that there is sensory feedback throughout the 
body that creates bends dependent on the received sensory information (Gjorgjieva).  
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Behaviors 
 
Figure 8​: Behaviors exhibited by C. elegans during locomotion (Yu ​et al., ​2013) 
 
​During locomotion, ​C. elegans ​exhibit several characterized behaviors that can be 
observed. For the purpose of this study, three main behaviors were observed and analyzed to 
understand the impact of β-Endorphins on locomotion. One observed behavior is the speed of the 
worm. The speed on the worm is defined as the number of micrometer per second moved over 
the distance of the experimental plate. Another observed behavior of locomotion was the 
amplitude of the worm. Amplitude is classically defined as the maximum displacement of points 
in a wave (Zesiger). In terms of ​C. elegans​, it is the displacement between the arcs created by the 
worm as it bends its body to propel itself forward. The last behavior being examined is the 
turning of the worms or their change of direction on the plate. These behaviors can be useful in 
determining if there are changes in locomotive ability.  
Methodology 
C. elegans​ maintenance  
The ​C. elegans​ used for this project were of the wild type strain. This strain was 
originally acquired from the Caenorhabditis​ ​Genetics Center (CGC). ​C. elegans ​were maintained 
on OP 50 seeded nutrient media plates. All ​C. elegans ​were incubated at 20° C to allow proper 
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development. Worms were moved every 3-4 days to new seeded plates to maintain healthy 
communities.  
Locomotion Assay  
Plates with sexually mature adult wild type worms were used for the locomotion assay. 
The plates were then washed with approximately .5 mL of sterile M9 and transferred to an 
eppendorf tube. The worms were allowed to settle in the tube for approximately 20 minutes. The 
supernatant was then removed and the washing procedure was repeated one more time. The 
worms in the tube were then exposed in the eppendorf tube to 200 µL of either sterilized PCR 
grade water (as a negative control) or the β-Endorphin solution. The worms were left to be 
exposed for either 10 minutes, 1 hour, or 2 hour intervals. After the exposure , the supernatant 
was removed and the worms were washed twice more with sterile M9 using the washing 
procedure outlined previously. The worms were then removed from the tubes and transferred to a 
30mm agar plate to acclimate for a 1 hour period. After the acclimation, 5 worms were then 
transferred from the acclimation plates to a fresh agar plates. The worms were then recorded 
using Worm Lab for a 20 minute interval.  
 
Figure 9​: Locomotion assay procedure for N2 (wildtype)  
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Analysis of Locomotion Videos 
Videos of wild type worm locomotion were analyzed using WormLab software. Each 
video was loaded into the software. The width of each plate was measured for each video to 
ensure proper tracking. Highlighting on each plate was set to 156. Background smoothing, 
Gaussian smoothing, and hotspot correction were also selected to help illuminate worms for 
tracking. A label was placed the illuminated portion of the agar portion of the plate with tracking 
being limited to this labeled area. This was done to ensure the tracking of only worms in 
illuminated agarose agar regions of the plate. Each of the five worms on tracked plates were 
detected using the manual detecting feature. Before each video, the frame rate limiting was set to 
35 frames. Each video was saved and then processed using the batch processing feature.  
Survey Instrument  
​A survey about opioid misconceptions at WPI was created with the assistance of a 
principal investigator, James Doyle and student co-author, Jessica Greenleaf. The survey 
contained 37 questions, related to beliefs and experiences of WPI students on the topic of 
opioids. The survey was created using qualtrics software. The SONA systems psychology portal 
was used to collect responses. 60 responses were collected from January through March of 2019. 
55% of responses were from those identifying as women, while 40% of responses were from 
those identifying as men. 86% of respondents were white. Each undergraduate class was evenly 
represented throughout survey responses. 
Results 
​This section will discuss how the concentration of β-Endorphin was determined. It will 
then present data from wild type locomotion trials. Lastly, this section will present findings from 
the β-Endorphin treatment of ​C. elegans.  
β-Endorphin Concentration  
β-Endorphin concentrations were found using a body mass ratio between rats and ​C. 
elegans​ exposed to punicalagin and β-Endorphins. ​C. elegan​s have not been tested with 
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β-Endorphins in previous studies and ratios for punicalagin concentrations were used from the 
MQP completed by Cosedine, Randle, and McNeill. Thus a body mass ratio derived from the 
concentration of punicalagin in both species was compared to β-Endorphins used in rats to find 
the β-Endorphin concentration of ​C. elegans.​  The concentration of β-Endorphin to use was 
determined to be 1.6e​-11 ​M β-Endorphin. 
 
 
 
 
 
 
 
x=1.6e​-11 ​M β-Endorphin 
 
Normalized Wild Type​ ​Data 
To determine baseline locomotive behavior, 4 trials of 5 worms were tracked according 
to the Worm Tracker software. Results of the trials are shown in Figure 10 below. 
 
 
Figure 10: Wild type ​C. elegans ​ Behavior (n=4). ​Wild type C. elegans locomotive behavior. The average speed of 
wild type C. elegans (top left), average amplitude (top right), and average turn count (bottom) are shown in this 
figure. Speed is the average speed over a 20 minute period. An N= 4 was used. Standard Error is graphed. 
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β-Endorphin Treatment 
​β-Endorphin, at a 16 pM concentration was applied to ​C. elegans ​for an hour. 
Comparisons of speed, amplitude, and Ω turn count between the water control and β-Endorphin 
treatment can be seen in Figure 11 below.  
 
 
 
  
Figure 11: Control vs. β-Endorphin behavior of ​C. elegans ​ (n=5). ​Wild type C. elegans locomotive behavior 
after exposure to sterile water versus exposure to 16 pM β-Endorphin treatment tracked over a 20 minute period. 
The figure shows average speed (left), average amplitude (center), and average Ω turn count (right). An N=5 was 
used. Standard error is plotted on all figures. A student t-test, two-sample assuming equal variances, was performed.  
  
 
 
Discussion 
​The survey instrument and β-Endorphin treatment of ​C. elegans ​were used to begin to 
study opiate addiction at WPI. The survey instrument showed that there is some awareness of the 
danger of opiates at WPI. However, it also showed that college students have more than one way 
to access opiates; through both prescriptions and recreationally. This section will discuss the 
results of the β-Endorphin treatment. It will also touch upon some limitations of the study as well 
as future directions.  
β-Endorphin Treatment versus Water Treatment 
The results from Figure X, seem to show that there may be a correlation between the 
speed of ​C. elegans ​and the β-Endorphin treatment. This study analyzed three main behaviors; 
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speed, amplitude, and turn count. The difference between the speed of the control and 
β-Endorphin treated worm was statistically significant (p<0.05). The control speed was around 
110 μm per second, while the β-Endorphin treated worm speed was around 70 μm per second. 
This is a fold change of about 1.5. 
Both the amplitude and Ω turn count of the control versus treated worms were not 
statistically significant. It is possible that this is due to a variability within these behaviors. The 
wild type locomotive behaviors, from Figure 10, show that the standard error of these 2 
behaviors is greater than that of speed.  The data of the β-Endorphin treated behaviors had a 
greater standard error than unexposed wild type worms. This indicates that exposure to 
β-Endorphin created more variability and less stability in the behaviors of normal ​C. elegans​.  
β-Endorphin does change wild type behavior of ​C. elegans ​to a degree. The statistically 
significant reduction of speed shows that the β-Endorphin is somehow interacting with ​C. 
elegans ​neural structure. The increased variability of movement could also be a result of 
interaction of β-Endorphin with ​C. elegans ​neural structure. Due to these correlations, ​C. elegans 
could be used with β-Endorphin as a method to test opioid addiction.  
Limitations 
​This study was limited by a variety of factors. These include timing of worm passing, the 
Worm Tracker software, and issues with maintaining consistencies with controls. The goal of the 
project was to look at both locomotion assays and egg-laying assays.  Egg laying was removed 
as an experimental observation after difficulty with initial tests on wild type worms. These issues 
stemmed from the inability to synchronize ​C. elegan ​populations for appropriate egg laying. 
They were not passed early enough in age, and therefore did not produce as many eggs as was 
expected based on other studies.  
Originally three β-Endorphin concentrations were tested to understand the range of 
effects on speed. However, only one β-Endorphin concentration, 16 pM, was included in this 
final report. The 1.6 and 160 pM concentrations were conducted but encountered difficulties in 
gathering data and interpreting the information. It is possible that the β-Endorphin could have 
degraded over time after being dissolved in water and stored in the freezer. However, there is no 
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literature that discusses if it degrades when dissolved in water. One complication was due to 
trouble with the Worm Tracker software. The software did not always produce data after analysis 
was conducted on a video. It was deduced that this was caused by various factors including: size 
of the worm, darkness of the worm’s body, exposure of the plate, or complications in opening 
multiple project windows in the software. Another persistent issue with the software was the 
inability to track more than one frame. This often made it difficult to analyze the videos captured 
from these experiments. 
 Another major issue was the lack consistency in wild type  controls. Controls had to be 
repeated multiple times due to fluctuations from previously viewed values. This could have been 
due to changing humidity and temperature in the laboratory. Observed behaviors in both controls 
and exposed worms fluctuate with temperature and humidity change. This made it difficult to 
keep observed data trend consistent. Lastly, time was a factor in the inability to complete 
analysis of the desired concentrations. The analysis process using the Worm Tracker software 
took extended periods of time. Due to multiple uses of the machine, it was difficult to reasonably 
time analysis of collected data.  
Some of these limitations could be resolved by studying egg-laying of ​C. elegans ​more in 
depth, potentially by finding a new procedure to replicate. To resolve some issues with the 
Worm Tracking software, it is important to ensure that it is up to date. It may also be beneficial 
to use smaller plates when recording, to improve resolution of the video taken. Lastly, another 
machine with the Worm Tracker software available would improve efficiency of video analysis. 
Future Directions 
Future studies with this project should focus on optimizing data analysis using the Worm 
Tracker software. There were some issues with the software itself that made it difficult to run 
batch analysis on multiple videos overnight. There were some times when the software would 
shut down before it was able to finish analysis. Due to this, it would be beneficial for future 
groups to familiarize themselves with the software at the beginning of the project. It would also 
be beneficial to contact the Worm Tracker representative, to understand what type of analysis 
would be best for them, depending on what behaviors their project is focused on.  
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The future directions of this project specifically include the expansion of concentrations 
analyzed in this study. In this study, only a 16 pM concentration was fully analyzed. The 16 pM 
concentration was a good starting concentration because it did show an effect on the speed of ​C. 
elegans. ​However, different concentrations could depict a stronger or weaker response to the 
β-Endorphin. There could be a concentration that is a lethal dose of β-Endorphin. While studies 
have shown that humans cannot overdose on β-Endorphin, it is possible that it could happen in 
C. elegans. ​This would be a beneficial way to model opioid overdoses.  
Exposure time could be another variable to test. This project only focused on a one hour 
exposure, but it is possible that a longer exposure could change observed behavior as well. It 
would be valuable to test exposures less than an hour to see if decreasing exposure time would 
yield a different behavioral changes. Multiple exposures on the same worms would model opioid 
addiction. A single individual would be exposed multiple times to the β-Endorphin over the 
course of a day, a few days, or even a week.  This chronic exposure can be compared to an acute 
exposure to understand differences between the two. 
 Furthermore, different assays can be conducted to understand β-Endorphins impact on 
other behaviors. One behavior that was considered but not added to this study was egg laying. It 
would be of interest to see how opiates impact the ability for worms to lay eggs. A biochemical 
study could be conducted to determine what is impacting the speed of ​C. elegans ​when treated 
with β-Endorphin versus the water control. Other assays, such as avoidance and attraction assays 
could be performed after β-Endorphin exposure. These are normal behaviors, that influence the 
success of an organism to feed and reproduce.  
There are many future directions to be explored with this project. However, the goal of 
the project was achieved. This project sought to determine if ​C. elegans ​and β-Endorphin can be 
used as a model of opioid addiction. While there are many more directions to explore, this 
baseline study showed that administering β-Endorphin at a 16 pM concentration reduced the 
speed of ​C. elegans​ but also increased variation in normal locomotive behaviors.  
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